Current Issue - March 2017, Volume 11, Issue No. 1

1. Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011; 105: 1795-803.
2. American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society 2015.
3. Fizazi K, Carducci M, Smith M, Damiao R, Brown J, Karsh L, et al. Denosumab versus zolendranic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet. 2011; 377: 813-22.
4. Bickels J, Dadia S, Lidar Z. Surgical management of metastatic bone disease. J Bone Joint Surg Am. 2009; 91: 1503-16.
5. Sorensen M, Gregersen KG, Grum-Schwensen T, Hovgaard D, Petersen MM. Patient and implant survival following joint replacement because of metastatic bone disease. Acta Orthop. 2013; 84: 301-6.
6. Li BT, Wong MH, Pavlakis N. Treatment and prevention of bone metastasis from breast cancer: A comprehensive review of evidence for clinical practice. J Clin Med. 2014; 3: 1-24.
7. Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk factor for those born from 1930 to 1960. Br J Cancer. 2015; 112: 943-7.
8. Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer. 2006 6(1): 63-74.
9. Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y, Funakoshi A, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroent Hepatology 2011; 13: 1083-8.
10. Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol. 2012; 4: 87-93.
11. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006; 12(20 suppl);6243-9.
12. Kuchuk I, Hutton B, Moretto, Ng T, Addison CL, Clemons M. Incidence, consequences and treatment of bone metastasis in breast cancer patients-Experience from a single cancer centre. J Bone Oncol. 2013; 2: 137-44.
13. Costa L, Badia X, Chow E, Lipton A, Wardleyn A. Impact of skeletal complications on patients quality of life, mobility and functional dependence. Support Care Cancer. 2008; 16: 879-89.
14. Gainor BJ, Buchert P. Fracture healing in metastatic bone disease. Clin Orthop. 1983;178: 297-302.
15. Sarahrudi K, Wolf H, Funovics P, Pajenda G, Hausmann JT, Vecsei V. Surgical treatment of pathological fractures of the shaft of humerus. J Trauma. 2009; 66: 789-94.
16. Perez CA, Bradfield JS, Morgan HC. Management of pathologic fractures. Cancer 1972: 29: 684-93.
17. Talbot M, Turcotte RE, Isler M, Normandin D, Iannuzzi D, Downer P. Function and health status in surgically treated bone metastases. Clin Orthop Rel Res. 2005; 438: 215-20.
18. Ji T, Guo W, Yang RL, Tang S, Sun X. Clinical outcome and quality of life after surgery for periacetabular metastasis. J Bone Joint Surg. 2011; 93: 1104-10.
19. Quan GMY, vital JM, Aurouer N. Surgery improves pain, function and quality of life in patients with spinal metastasis: a prospective study on 118 patients. Eur Spine J. 2011; 20: 1970-8.
20. Ji T, Eskander R, Wang Y, Sun K, Hoang BH, Guo W. Can surgical management of bone metastasis improve quality of life among women with gynaecological cancer? World J Surg Oncol. 2014; 12: 250.
21. Bohm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg Br. 2002; 84: 521-9.
22. Cool P, Grimer R. Pathological fractures of the extremities. Trauma. 2000; 2: 101-11.
23. Ahlmann ER, Menedez LR, Kermani C, Gotha H. Survivorship and outcome of modular endoprosthesis reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg. 2006; 88: 790-5.
24. Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesion of the proximal femur. J Bone Joint Surg. 2005;87: 1653-7.
25. Nakashima H, Katagiri H, Takahashi M, Sugiura H. Survival and ambulatory function after endoprosthetic replacement for metastatic bone tumour of the proximal femur. Nagoya J Med Sc. 2010; 72: 13-21.
26. Frassica DA, Manoso MW, Lietman SA, Frassica FJ. Proximal replacement for metastatic bone disease. Orthopaedics. 2007; 30. doi 10.3928/01477447-20070501-09.
27. Nillson J, Gustafson P. Surgery for metastatic lesions of the femur: Good outcomes after 245 operations in 216 patients. Injury. 2008; 39: 404-10.
28. Tan PK, Tan MH. Functional outcome study of mega-endoprosthetic reconstruction in limbs with bone tumour surgery. Ann Acad Med. 2009; 38: 192-6.
29. Unwin PS, Cannon SR, Grimer RJ, Kemp HB, Sneath RS, Walker PS. Aseptic loosening in cemented custom made prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg. 1996; 78: 5-13.
30. Dobbs HS, Scales JT, Wilson JN, kemp HBS, Jackson Burrows H, Sneath RS. Endoprosthetic replacement of the proximal femur and acetabulum. J Bone Joint Surg. 1981; 63: 219-24.
31. Harvey N, Ahlmann ER, Allison DC, Lingjun W, Menendez LR. Endoprosthesis last longer than intramedullary devices in proximal femoral metastases. Clin Orthop Rel Res. 2012; 470: 684-91.
32. Ramakrishnan M, Prasad SS, Parkinson RW, Kaye JC. Management of subtrochanteric femoral fractures using long proximal femoral nail. Injury. 2004; 35: 184-90.
33. Harrington KD. Orthopaedic management of extremity and pelvic lesions. Clin Orthop. 1995; 312: 136-47.
34. Kerr PS, Jackson M, Atkins RM. Cardiac arrest during intramedullary nailing for femoral metastases. J Bone Joint Surg. 1993; 75: 972-3.
35. Choong PFM. Cardiopulmonary complications of intramedullary fixation of long bone metastases. Clin Orthop Rel Res. 2003; 415:S245-S253.
36. Cole AS, Hill GA, Theologis TN, Gibbons CLMH, Willet K. Femoral nailing for metastatic disease of the femur: a comparison of reamed and unreamed femoral nailing. Injury. 2000;31: 25-31.
37. Anglen J, Kyle RF, Marsh JL, Virkus WW, Watters WC 3rd, Keith MW, et al. Locking plates for extremity fractures. J Am Acad Orthop Surg. 2009; 17: 465-72.
38. Seo CY, Jung ST. Metastatic pathologic fractures in lower extremities treated with the locking plate. J Korean Bone Tumor Soc. 2010; 16: 80-6.
39. Dijstra S, Wiggers T, Geel BTV, Boxma H. Impending and actual pathological fractures in patients with bone metastases of long bones: A retrospective study of 233 surgically treated patients. Eur J Surg. 1994; 160: 535-42.
40. Bauer HCF. Controversies in the surgical management of skeletal metastasis. J Bone Joint Surg. 2005; 87: 608-17.
41. Clohisy DR, Le CT, Cheng EY, Dykes DC, Thompson RC. Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases. J Orthop Res. 2000; 18: 1-9.

Abstract   |   Reference